Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 79,176 | 78,058 | 76,511 | 74,203 | 72,942 |
| Cost of Goods | 30,983 | 29,694 | 37,524 | 49,088 | 46,754 |
| Gross Profit | 48,193 | 48,364 | 38,987 | 25,115 | 26,188 |
| Operating Expenses | 29,550 | 32,509 | 34,450 | 27,576 | 33,317 |
| Operating Income | 19,626 | 16,549 | 5,061 | -2,373 | -6,375 |
| Interest Expense | 8,063 | 8,259 | 4,823 | 211 | 228 |
| Other Income | 3 | 14 | 212 | 383 | 494 |
| Pre-tax Income | 11,566 | 8,304 | 450 | -2,201 | -6,109 |
| Income Tax | 280 | 246 | N/A | N/A | N/A |
| Net Income Continuous | 11,286 | 8,058 | 450 | -2,201 | -6,109 |
| Net Income | $11,286 | $8,058 | $450 | $-2,201 | $-6,109 |
| EPS Basic Total Ops | 0.33 | 0.23 | 0.01 | -0.07 | -0.18 |
| EPS Basic Continuous Ops | 0.33 | 0.23 | 0.01 | -0.06 | -0.18 |
| EPS Diluted Total Ops | 0.32 | 0.23 | 0.01 | -0.07 | -0.18 |
| EPS Diluted Continuous Ops | 0.32 | 0.23 | 0.01 | -0.06 | -0.18 |
| EBITDA(a) | $36,616 | $33,540 | $15,554 | $1,511 | $-2,507 |